Anyone—healthy or diseased, with a few exceptions—benefits from regular transfer factor supplementation. The use of transfer factor has resulted in no reports of serious adverse reactions, even when clinically administered in doses in excess of normal for prolonged periods.

Those with specific ailments also benefit. Numerous studies have shown the effectiveness of transfer factor in eliminating or aleviating symptoms of herpes, chronic fatigue syndrome, epstein barr, hepatitis, secondary infection due to AIDS, candida, cancer and many other disorders. Studies have also shown than continual use provides the greatest benefit with maximum immune activity occuring 24 to 48 hours after initial dosing.

The need for transfer factor as an adjunct to better health stems from the growing awareness that prevention is the best source of treatment. With the increasing risks of antibiotic resistance and significant health threats, such as SARS, the medical community increasingly turns to the inherent concept of vaccines—prevention.

Transfer factors are akin to vaccines. But, rather than expose the patient’s immune system to the actual disease or a deactivated version of the same, transfer factors expose the patient’s immune system to the memory of a health threat—whether foreign or native—and the knowledge of how to best respond to protect itself.

Sources:
http://www.transferfactorinstitute.c...ctor/needs.cfm

http://www.ncbi.nlm.nih.gov/entrez/q...arch&DB=pubmed